Effects of Two Weight-Loss Medications, Liraglutide and Orlistat, on Liver Enzymes in Patients with Overweight or Obesity in a Real-World Setting

被引：1
|
作者：
Gorgojo-Martinez, Juan J.
Chicharro, Pablo L. Lois
Ferreira-Ocampo, Pablo J.
Doejo-Marciales, Sandra C.
Barra-Malig, Solange F.
Almodovar-Ruiz, Francisca
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-1440-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1440-P
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Weight loss and persistence with liraglutide 3.0 mg by obesity class in the real-world effectiveness study in Canada
    Wharton, Sean
    Haase, Christiane L.
    Kamran, Elham
    Liu Aiden
    Mancini, Johanna
    Neish, Drew
    Pakseresht, Arash
    Power, G. Sarah
    Christensen, Rebecca A. G.
    OBESITY SCIENCE & PRACTICE, 2020, 6 (04): : 439 - 444
  • [12] Weight Loss and Fecundity Among Women with Overweight or Obesity: A Real-World Data Cohort Study
    Verfurden, Maximiliane
    Schnecke, Volker
    Winning-Lehmann, Eva
    Uppal, Shweta
    Sommer, Kasper
    Balen, Adam
    OBESITY, 2023, 31 : 40 - 41
  • [13] Persistence of newer anti-obesity medications in a real-world setting
    Ganguly, Rahul
    Tian, Ye
    Kong, Sheldon X.
    Hersloev, Malene
    Hobbs, Todd
    Smolarz, B. Gabriel
    Ramasamy, Abhilasha
    Haase, Christiane Lundegaard
    Weng, Wayne
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 143 : 348 - 356
  • [14] Use of Liraglutide 3.0 mg for Weight Management in a Real-World Setting in Switzerland
    Haase, Christiane Lundegaard
    Serratore Achenbach, Maria Giovanna
    Lucrezi, Gianluca
    Jeswani, Nikita
    Maurer, Susanne
    Egermann, Ulrich
    OBESITY FACTS, 2021, 14 (05) : 568 - 576
  • [15] Use of liraglutide and dulaglutide for weight loss: real-world observations on efficacy and tolerability
    Ludgate, S.
    Kennedy, C.
    Ho, K.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 : S234 - S235
  • [16] Adherence to and Dropout from Liraglutide 3.0 mg Obesity Treatment in a Real-World Setting
    Ko, Hae-Jin
    Kim, Jin-Wook
    Lim, Soo
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2022, 31 (03) : 254 - 262
  • [17] Effectiveness of an Email-Based, Semaglutide-Supported Weight-Loss Service for People with Overweight and Obesity in Germany: A Real-World Retrospective Cohort Analysis
    Talay, Louis
    Vickers, Matt
    Ruiz, Laura
    OBESITIES, 2024, 4 (03): : 256 - 269
  • [18] Tirzepatide and MASLD: Real-World Outcomes in Patients With Overweight and Obesity
    Espinosa, Maria A.
    Fansa, Sima
    Anazco, Diego
    Ghusn, Wissam
    Elif, Tama
    Cifuentes, Lizeth
    Alejandro, Campos
    Rivera, Rene
    Hurtado, Maria D.
    Acosta, Andres
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1513 - S1514
  • [19] Weight Loss Targets Realization by Patients Living with Overweight or Obesity-Real World Data
    Oieru, Dan
    Haikin, Bozhena
    Moisa, Noy
    OBESITY, 2023, 31 : 162 - 162
  • [20] Real World Weight Loss Outcomes of Semaglutide in Patients With Overweight and Obesity After Bariatric Surgery
    Ghusn, Wissam
    Gala, Khushboo S.
    De La Rossa, Alan
    Cifuentes, Lizeth
    Sacoto, Daniel
    Campos, Alejandro
    Feris, Fauzi
    Hurtado, Maria D.
    Acosta, Andres
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1044 - S1045
12345